In Vitro Antimycobacterial Activities of Capuramycin Analogues

Por Reddy, Venkata M., Einck, Leo, Nacy, Carol A.
Publicado em 2008

In Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207

Por Reddy, Venkata M., Einck, Leo, Andries, K., Nacy, Carol A.
Publicado em 2010

Chemical modification of capuramycins to enhance antibacterial activity

Por Bogatcheva, Elena, Dubuisson, Tia, Protopopova, Marina, Einck, Leo, Nacy, Carol A., Reddy, Venkata M.
Publicado em 2011

Therapeutic Efficacy of SQ641-NE against Mycobacterium tuberculosis

Por Nikonenko, Boris, Reddy, Venkata M., Bogatcheva, Elena, Protopopova, Marina, Einck, Leo, Nacy, Carol A.
Publicado em 2014

Activity of SQ641, a Capuramycin Analog, in a Murine Model of Tuberculosis

Por Nikonenko, Boris V., Reddy, Venkata M., Protopopova, Marina, Bogatcheva, Elena, Einck, Leo, Nacy, Carol A.
Publicado em 2009

In vitro antimicrobial activities of capuramycin analogues against non-tuberculous mycobacteria

Por Dubuisson, Tia, Bogatcheva, Elena, Krishnan, Manju Y., Collins, Michael T., Einck, Leo, Nacy, Carol A., Reddy, Venkata M.
Publicado em 2010

Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641

Por D’Addio, Suzanne M., Reddy, Venkata M., Liu, Ying, Sinko, Patrick J., Einck, Leo, Prud’homme, Robert K.
Publicado no Mol Pharm (2015)